MET and non-small cell lung carcinoma: Key mutations associated with NSCLC development include mutations in epidermal growth factor receptor (EGFR), rearrangements in anaplastic lymphoma kinase and ROS1, and alterations in MET (Griffin and Ramirez, 2017[4]).